Almirall SA (ALM.MC)

ALM.MC on Madrid SE C.A.T.S.

18 Sep 2014
Price Change (% chg)

€-0.19 (-1.62%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ALM.MC


Almirall SA is a Spain-based company principally engaged in the research, development, storage and distribution of pharmaceutical products. The Company’s range of products include a variety of drugs for the treatment of diseases in such therapeutic areas as asthma, chronic obstructive pulmonary disease (COPD), gastrointestinal... (more)


Beta: 0.54
Market Cap (Mil.): €2,025.26
Shares Outstanding (Mil.): 172.95
Dividend: 0.15
Yield (%): 1.31


  ALM.MC Industry Sector
P/E (TTM): -- 32.66 33.47
EPS (TTM): -0.19 -- --
ROI: -2.60 18.15 17.39
ROE: -3.63 18.86 18.25
Search Stocks

Almirall says in deal with Astrazeneca over respiratory business

MADRID, July 30 - Spain's Almirall on Wednesday said it had reached a deal to transfer to Astrazeneca the rights of its respiratory franchise for an initial $875 million. (Reporting by Julien Toyer; Editing by Tracy Rucinski)

30 Jul 2014

AstraZeneca boosts lung drug business with up to $2.1 bln Almirall deal

LONDON, July 30 - AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion to acquire the rights to lung drugs developed by Spain's Almirall.

30 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters StreetEvents
Provider: GlobalData
Provider: GlobalData
Provider: Thomson Reuters StreetEvents
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks